DAVID MCMAHON: Open Payments
NPI 1457662249 · GREEN BAY, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 100 payments from 18 companies in 2025. Trend: 2023 $202 · 2024 $1,396 · 2025 $2,095
Food & beverage: $1,869Education: $227
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $390 |
| Axsome Therapeutics, Inc. | 23 | $331 |
| ABBVIE INC. | 14 | $290 |
| Teva Pharmaceuticals USA, Inc. | 4 | $261 |
| Lundbeck LLC | 6 | $130 |
| Otsuka America Pharmaceutical, Inc. | 7 | $129 |
| Collegium Pharmaceutical, Inc. | 6 | $117 |
| Indivior Inc. | 3 | $87 |
| Neurocrine BioSciences, Inc. | 5 | $74 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
Products named: ARISTADA, Auvelity, VRAYLAR, REXULTI, Jornay PM, SUBLOCADE, INGREZZA, Qelbree.
Industry payments across WI — which companies pay providers there.
